Clinical trials: Degenerative Spinal Disease

Degenerative Disc Disease

Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty

• Completed
• Age: 18 years and older
• Medical device
• Results posted

The NuBac device is indicated for reconstruction following nucleotomy in skeletally mature patients at least 18 years of age with symptomatic single level degenerative disc disease (DDD) at L4/L5 only.

Trial name

NCT00931515

Testing

NuBac, Prodisc-L

Where

17 sites in United States

Volunteers

30 people

Sponsor

Pioneer Surgical Technology, Inc.